What is PEG-MGF?

The short answer

PEG-MGF is a synthetic peptide with a polymer attached. The peptide part, sold on its own as MGF, copies the last 24 residues of the E domain of one IGF-1 splice variant. The PEG part is a polyethylene glycol chain, the kind of polymer attached to several licensed protein medicines to make them last longer.

The research behind it is less tidy, and the first thing to know is that "MGF" has named at least three different molecules.

One name, three different molecules

A messenger RNA. In 1996, Yang, Goldspink and colleagues extracted RNA from rabbit muscle induced to grow by active stretch. Alongside the usual IGF-1 transcript they found a second one with a short insert in the region coding for the E domain, which shifts the reading frame and produces a different C-terminal tail. Resting muscle contained little or none of it, and the variant was named mechano growth factor. In humans the equivalent is IGF-1Ec; in rodents it is IGF-1Eb, and papers do not always say which convention they follow.

A synthetic peptide. Researchers then made a 24-residue peptide matching the end of that unique E domain and tested it on cells. It inherited the MGF name, and it is what most of the literature and almost all of the market mean by "MGF peptide".

A recombinant protein. In 2014 an anti-doping laboratory analysed a product offered as "full-length MGF" and found a protein of roughly 12 kDa, closely related to IGF-1Ec but with sequence changes at its C-terminus. That is a third molecule, many times larger than the peptide.

The gap between the first two matters. A 2010 review in Endocrinology noted that while the variant messenger RNA is real and regulated, no free peptide corresponding to synthetic MGF had been identified in cultured cells, their medium, animal tissue or body fluids. The synthetic peptide models a fragment that may not exist as a separate molecule in the body.

What PEGylation changes

PEGylation means attaching polyethylene glycol chains to a protein or peptide. A widely cited review by Harris and Chess sets out the general effects: the conjugate becomes much larger, which slows its removal by the kidneys, and the polymer partly shields the backbone from enzymes that would otherwise cut it. For a short, enzyme-sensitive peptide those are the obvious motivations.

The same chemistry makes the product harder to characterise. PEG reagents are usually mixtures of chain lengths, so a PEGylated peptide shows a spread of masses rather than one exact mass, and where the chain is attached changes what the molecule is. A purity percentage alone says little about any of that.

We searched PubMed in October 2026 for peer-reviewed work characterising a PEGylated MGF peptide of the kind sold as PEG-MGF and found none. Stabilised MGF peptides do appear in the literature; the product on sale, as far as we can tell, has no published characterisation.

What the early research reported

Most positive findings come from the group that named the molecule and its collaborators:

• Myoblast culture. Yang and Goldspink reported in 2002 that, in a myoblast culture model, the E-domain peptide increased proliferation and inhibited terminal differentiation, and that blocking the IGF-1 receptor did not stop this, suggesting a different receptor.
• Human muscle cells. Kandalla and colleagues reported in 2011 that the peptide extended the proliferative lifespan of muscle precursor cells cultured from neonatal and young adult donors, but not from older adult donors.
• Brain ischaemia. Dluzniewska and colleagues reported in 2005 that the peptide protected vulnerable neurons in a gerbil model of transient ischaemia and in cultured hippocampal slices, again apparently independently of the IGF-1 receptor.

Each is a finding in a specific culture or animal model, not in people.

The replication problem

In 2014, Fornaro and colleagues at two pharmaceutical companies tried to reproduce the muscle findings. They reported that the peptide did not increase proliferation of a mouse myoblast line or of primary human myoblasts, did not inhibit their differentiation, and had no significant effect on primary mouse muscle stem cells. Native and stabilised versions also failed to activate a signalling pathway previously reported in heart muscle cells. Mature IGF-1 and the full-length splice variant did produce responses in the same experiments, so the assays could detect an effect. The authors concluded that their results question whether MGF has a physiological role at all.

One negative study does not close a question. But a controlled negative result, alongside the absence of a naturally occurring peptide, weighs heavily against the confident claims made for MGF online.

Why identity matters more than usual

A vial labelled MGF or PEG-MGF could contain a 24-residue peptide, a PEGylated version with an undefined polymer, or a recombinant protein several times larger. A certificate therefore has to establish which molecule is present, by mass and sequence, before any purity figure means much. Our guide to certificates of analysis explains what a certificate can show, and the guide to IGF-1 LR3 covers the mature growth factor MGF keeps being compared with.

Where MY PEPTIDES stands

We do not supply MGF or PEG-MGF, we hold no certificates for either, and nothing on this page is an offer to source them. Anything we do sell appears in the catalogue with its batch documentation.

The bottom line

MGF names an IGF-1 splice variant found in stretched muscle and, by extension, a synthetic 24-residue peptide copied from its E-domain tail; PEG-MGF adds a polyethylene glycol chain. The early findings came largely from one group, a careful industry replication found no effect, no matching peptide has been isolated from the body, and PEG-MGF itself has no published characterisation that we could find. We do not stock it.

All compounds referenced on this site are discussed strictly in the context of in-vitro laboratory research. Nothing here is a medicine, a supplement or a therapeutic product, nothing here describes administration to humans or animals, and this guide is general information rather than medical, legal or research advice.